Jump to Main Content

COVID-19 Resources

(Updated April 10, 2020)

The United States and countries around the world face a major public health concern with the current outbreak of the novel (new) coronavirus (COVID-19). In an effort to serve its members, ASH is maintaining this webpage as a medium to exchange information to assist hematologists in navigating the COVID-19 public health crisis.

While ASH aims to provide a forum for the exchange of information that is helpful, accurate and up-to-date, the relevant health information and data concerning the disease, as well as the various governmental actions and responses to the disease, are changing constantly, and ASH makes no representation, warranty, or guaranty whatsoever as to any information that may be exchanged through this webpage.

It remains the responsibility of each medical professional to decide on the appropriate medical advice, diagnosis, and treatment for patients. In rendering such advice, please bear in mind that although ASH attempts to include on this page information from reliable sources, it has not conducted a substantive review of each item posted below, nor does it have access to sufficient information to police potential conflicts of interest. Particularly given the exigencies presented by the current COVID-19 pandemic, we urge you to assist us identifying information that has been particularly helpful to you so that we might more prominently feature it, as well as any information that is inaccurate, outdated or inappropriate so that we can remove it.

President's Message:

As the world grapples with the novel coronavirus, ASH believes that we can help each other be as knowledgeable and prepared as possible. The information and links below will get us started but please let us know how ASH can help you, your center and your patients. The website will be updated frequently and new features added as needed.

-- ASH President Stephanie J. Lee, MD, MPH 

Latest Updates

Frequently Asked Clinical Questions contains information about COVID-19 and clinical hematology topics, including:

Resources for Clinicians

Academic Centers, Hospitals, and Community Practices

Frequently Asked Clinical Questions

Malignant Topics

Non-malignant Topics

Practice Issues

COVID-19 Treatments

Experience from the Field

COVID-19 Registries for Hematologic Conditions

  • ASH RC COVID-19 Registry for Hematologic Malignancy
    The ASH Research Collaborative’s (ASH RC) Data Hub is capturing data on people who test positive for COVID-19 and have been or are currently being treated for hematologic malignancy. As data are received, near real-time observational data summaries are reported for clinicians on the front line of the COVID-19 pandemic. Clinicians and other health care providers worldwide are invited to enter de-identified data on all confirmed COVID-19 cases for malignant hematology patients, regardless of recovery or active treatment status. Online data entry takes approximately 5 minutes to complete.
  • Secure-SCD Registry (Medical College of Wisconsin)
    This registry is designed to capture pediatric and adult COVID-19 cases that are occurring across the world in patients living with sickle cell disease.
  • CCC19 (COVID-19 and Cancer Consortium)
    A consortium of over 50 cancer centers and other organizations who have come together to collect data about cancer patients who have been infected with COVID-19.

American Society of Hematology

Chinese National Health Commission

  • Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment
    The Chinese National Health Commission has published "Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment." The document, in its 7th version and translated by the Chinese Society of Cardiology, reflects deeper understanding of the clinical manifestations and pathological features of the disease and "the accumulation of experience in diagnosis and treatment."

The First Affiliated Hospital, Zhejiang University School of Medicine

  • Handbook of COVID-19 Prevention and Treatment
    COVID-19 Handbook from the Chinese experience from The First Affiliated Hospital, Zhejiang University School of Medicine 28 MB, 68 pages covering prevention and control management, diagnosis and treatment, nursing.

Additional Resources

COVID Ready Communication Skills: A playbook of VitalTalk Tips (a toolkit of talking points about COVID-19)

American Society of Hematology

Sickle Cell Disease and COVID-19: An Outline to Decrease Burden and Minimize Morbidity (An international body of experts provides weekly updated recommendations for providers who may encounter sickle cell patients suspected of being infected with COVID-19)

ELSO (Extracorporeal Life Support Organization)

Anticoagulation with ECMO by Dr. Raffini

HHS (Department of Health and Human Services)

Anticoagulation Forum

COVID-19: General Resources

Global COVID-19 Data (updated frequently)

COVID-19 in the US and Canada (includes state and county-level data)

AMA (American Medical Association)

CDC (Centers for Disease Control and Prevention)

WHO (World Health Organization)

ASH Summary of the Coronavirus Aid, Relief and Economic Security (CARES) Act

Subspecialty Societies

AABB (American Association of Blood Banks)

ACP (American College of Physicians)

ASCO (American Society of Clinical Oncology) 

ASTCT (American Society for Transplantation and Cellular Therapy)

EHA (European Hematology Association)


New England Journal of Medicine

JAMA (Journal of the American Medical Association)

The Lancet

Journal of Thrombosis and Haemostasis


Additional Resources

Resources for Researchers

AHRQ (Agency for Health Research and Quality)

American Society of Hematology

FDA (Food and Drug Administration)

NIH (National Institutes of Health)

Other Resources

  • Keeping Blood Science Education Moving Forward 
    Dr. Kellie Machlus from Harvard Medical School and Brigham and Women’s Hospital has organized this weekday webinar series (1:00 p.m. Eastern) to continue scientific education during this time of travel restrictions and meeting rearrangements.
  • Connecting the Scientific Community Seminar Series 
    Drs. Kornelia Polyak and David Weinstock from Dana-Farber/Harvard Cancer Center have organized this seminar series (12:00 pm Eastern Mondays, Tuesdays,Thursdays, and Fridays) to facilitate scientific exchanges during the COVID-19 restrictions.

Is there a hematology-related COVID-19 resource that has been helpful to you that is not listed here? Is there content here that's inappropriate or outdated? Are there specific issues or questions that ASH can help to address? We welcome your feedback below.

Get Updates

Sign up for email updates to stay abreast of the latest COVID-19 resources recommended by the American Society of Hematology.

Sign up for Email Updates